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Abstract
Background: We aimed to define the frequency and predictors of successful external cephalic version in a
nationally-representative cohort of women with breech presentations and to compare maternal outcomes
associated with successful external cephalic version versus persistent breech presentation.
Methods: Using the Nationwide Inpatient Sample, a United States healthcare utilization database, we identified
delivery admissions between 1998 and 2011 for women who had successful external cephalic version or persistent
breech presentation (including unsuccessful or no external cephalic version attempt) at term. Multivariable logistic
regression identified patient and hospital-level factors associated with successful external cephalic version. Maternal
outcomes were compared between women who had successful external cephalic version versus persistent breech.
Results: Our study cohort comprised 1,079,576 delivery admissions with breech presentation; 56,409 (5.2 %) women
underwent successful external cephalic version and 1,023,167 (94.8 %) women had persistent breech presentation at
the time of delivery. The rate of cesarean delivery was lower among women who had successful external cephalic
version compared to those with persistent breech (20.2 % vs. 94.9 %; p < 0.001). Compared to women with persistent
breech at the time of delivery, women with successful external cephalic version were also less likely to experience
several measures of significant maternal morbidity including endometritis (adjusted Odds Ratio (aOR) = 0.36, 95 %
Confidence Interval (CI) 0.24–0.52), sepsis (aOR = 0.35, 95 % CI 0.24–0.51) and length of stay > 7 days (aOR = 0.53, 95 %
CI 0.40–0.70), but had a higher risk of chorioamnionitis (aOR = 1.83, 95 % CI 1.54–2.17).
Conclusions: Overall a low proportion of women with breech presentation undergo successful external cephalic
version, and it is associated with significant reduction in the frequency of cesarean delivery and a number of measures
of maternal morbidity. Increased external cephalic version use may be an important approach to mitigate the high rate
of cesarean delivery observed in the United States.
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Background
The last two decades have seen a rise in the frequency of
cesarean delivery (CD) in the United States, primarily
due to a rise in the rate of primary CD [1]. This trend in
CD frequency has been associated with an increase in
the rate of maternal morbidity, which is at least partly
attributable to the increased risk for adherent placenta
in subsequent deliveries, uterine rupture, and maternal
hemorrhage [2–4]. Breech presentation accounts for ap-
proximately one-fifth of all primary CDs [1, 5].
Cesarean delivery has become the preferred breech de-
livery option in both the developed and developing
world [6, 7] due to improved neonatal outcomes com-
pared with breech vaginal delivery [8]. In the developed
world, increased breech CD rates have been reported in
the United States, New Zealand, and Europe [1, 9, 10].
In 2010, 16 of 21 European countries reported breech
presentation CD rates of greater than 80 %; Norway had
the lowest breech presentation CD rate, at 69 % [9].
External cephalic version (ECV) has the potential to re-
duce the incidence of CD, [11–13] and is endorsed by the
American College of Obstetricians and Gynecologists
(ACOG) and the Royal College of Obstetricians and Gynae-
cologists (RCOG) [6, 13]. Successful ECV can facilitate a
planned vaginal delivery, which may be associated with re-
duced maternal morbidity compared with planned CD [14].
Detailed ECV outcomes for women with singleton breech-
presentation in the United States have been reported in
single-center studies [15, 16]. Maternal outcomes following
successful ECV compared with persistent breech presenta-
tion delivery have not been examined.
Using a nationally representative database of United
States delivery admissions, we aimed to define the fre-
quency and predictors of successful ECV among women
with breech presentation in the United States. We also
sought to compare maternal outcomes associated with
successful ECV versus persistent breech presentation
during the delivery admission.
Methods
Data source
Data were derived from the Nationwide Inpatient Sample
(NIS) (1998–2011) database, maintained by the Agency
for Healthcare Research and Quality as part of its Health-
care Cost and Utilization Project, and is the largest all-
payer discharge database in the United States. Additional
details regarding the database are available at: http://
www.hcup-us.ahrq.gov/.
The NIS contains demographic data such as age, race,
and the primary expected payer for the hospital admis-
sion. Diagnoses and procedures associated with each ad-
mission are coded using the International Classification of
Diseases, Ninth Revision, Clinical Modification manual
(ICD-9-CM). Each year approximately 1000 hospitals,
representing all types of health facilities, are selected for
the NIS database. Hospitals are selected for inclusion in
order to create a sample that is maximally representative
of all types of health facilities in United States admissions.
All admissions data from these hospitals are included in
the database; this dataset includes information on approxi-
mately 20 % of United States hospital admissions. Using
analytical sample weights can provide national estimates
derived using the data.
Cohort
We identified women admitted for delivery who had a
breech presentation or a successful ECV during pregnancy
using ICD-9-CM codes, using the NIS database during
1998–2011, as has been utilized previously [17, 18]. A
code for successful ECV, 652.1x, identified women whose
fetus had previously been breech and had undergone suc-
cessful version to cephalic presentation (either before or
during the delivery admission). The breech presentation
group, 652.2x, comprised all women with persistent
breech presentation during the delivery admission; there
were no codes that can differentiate women who had an
unsuccessful ECV attempt from those who did not
undergo ECV prior to the delivery admission.
Based on the most recent ACOG and RCOG guide-
lines for ECV, and recommendations from clinical
experts, [6, 13, 19] we excluded: admissions with spon-
taneous preterm labor and delivery (below 37 complete
weeks); conditions that are relative or absolute contrain-
dications to performing ECV including multiple gesta-
tions, prior CD, human immunodeficiency virus (HIV),
placenta previa or accreta, uterine anomalies, oligohy-
dramnios; and maternal age <16 years. The exclusion
criteria were identified by ICD-9-CM diagnosis codes
recorded at the time of admission for delivery.
Analysis
We examined patient- and hospital-level factors associ-
ated with successful ECV. Specific patient, obstetric and
hospital characteristics were selected a priori as poten-
tial predictors of successful ECV, based on our literature
review and clinical plausibility [6, 13, 20]. For patient
characteristics, we assessed: maternal age (categorized as
16 to 19 years, 20 to 34 years, 35 to 39 years, and 40 years
or older), race/ethnicity (categorized as white, black,
Hispanic, Asian/Pacific Islander, other, and missing), and
primary expected payer (categorized as Medicaid, Medi-
care, Private Insurance, self-pay, no charge, and other).
For obstetric factors, we assessed: diabetes (gestational
and pre-existing), hypertensive disease of pregnancy,
grandmultiparity, and fetal growth restriction. Individual
hospital characteristics were assessed, including: annual
hospital delivery volume (categorized as < =1,000, 1,001 to
2,000, 2,001 to 4,000, and >4,000 deliveries per year) and
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annual hospital CD frequency (categorized as <20 %,
20–24 %, 25–29 %, 30–34 %, ≥35 %). All covariates
were entered into a multivariable logistic regression
model to examine predictors of successful ECV (ver-
sus persistent breech). Adjusted odds ratios (aOR)
and 95 % confidence intervals (CI) are reported.
To compare maternal outcomes between women who
underwent successful ECV versus those with persistent
breech presentation at delivery, we fit separate multivariable
logistic regression models for the following conditions: CD,
thromoboembolic phenomena, anesthesia complications,
chorioamnionitis, endometritis, sepsis, blood transfusion,
hysterectomy, and length of stay greater than 7 days. We
also performed linear regression analyses to assess inde-
pendent associations between successful ECV versus per-
sistent breech presentation at the delivery admission and
total hospital length of stay and hospital charges. All regres-
sion models were adjusted for the demographic, obstetrical,
and hospital characteristics noted above.
Information on attempted ECV during the delivery ad-
mission was available in our database using the ICD-9-
CM procedure code 73.91. This enabled a secondary
analysis of maternal outcomes for attempted ECV per-
formed during the delivery admission.
This secondary analysis was restricted to ECV per-
formed during the delivery admission, ICD-9-CM pro-
cedure code 73.91 (during delivery admission ECV
would only be performed for breech presentation) versus
without ECV attempt (all other women with persistent
breech presentation at delivery, 652.2x). Successful ECV
during the delivery admission was available in our data-
base using the ICD-9-CM code 652.1x for women who
had attempted ECV during the delivery admission (ICD-
9-CM procedure code 73.91).
All analyses accounted for the complex survey design
of the NIS [4, 17]. Statistical analyses were performed
using Stata Statistical Software: Release 12.1 (Stata-
Corp LP, College Station, TX). Admissions with miss-
ing payer (n = 2481) or age (n = 690) were excluded
from adjusted analyses.
Results
Between 1998 and 2011, there were 1,861,574 delivery
admissions with successful ECV or persistent breech pres-
entation. Of these, 781,998 (42 %) women underwent pre-
term delivery or were coded in the NIS database with at
least one relative or absolute contraindication to ECV and
were excluded from the cohort. Our leading reasons for
exclusion from the cohort were spontaneous preterm de-
livery (n = 388,863), prior CD (n = 287,728), multiple ges-
tations (n = 141, 758), and oligohydramnios (n = 120,962).
The full exclusions are presented in Table 1. In the final
analytic cohort, 56,409 (5.2 %) women underwent success-
ful ECV during or prior to the delivery admission and
1,023,167 (94.8 %) women had persistent breech presenta-
tion at the time of delivery.
Maternal demographic, clinical, and hospital charac-
teristics are presented in Table 2. Compared to women
aged between 20 to 34 years, younger women were less
likely and older women more likely to have undergone
successful ECV. Compared to women whose deliveries
were covered by Medicaid (low- to no-income families
and individuals), those covered by Medicare or private
insurance were less likely to have a successful ECV.
Women who underwent successful ECV were less likely
to have hypertensive disease or a fetus with intrauterine
growth restriction (IUGR) and more likely to be grand-
multiparas (≥5 previous deliveries). There was a strong
inverse relationship between annual hospital CD fre-
quency and successful ECV. Successful ECV was approxi-
mately one-third less likely among women who delivered
at hospitals with annual CD frequency ≥35 %, compared
to women who delivered at hospitals with low annual CD
frequency, <20 %, controlling for other factors (Table 2).
No association was observed between annual hospital de-
livery volume and frequency of successful ECV.
Among women who underwent successful ECV, the
CD frequency was 20.2 % whereas the CD frequency
among women with persistent breech presentation deliv-
ery was 94.9 % (P < 0.001). Table 3 shows the association
between successful ECV and maternal obstetrical out-
comes, adjusted for potentially confounding variables.
Compared to women with persistent breech presenta-
tion, women who underwent successful ECV had a
lower odds of developing endometritis (aOR 0.36, 95 %
CI 0.24–0.52), sepsis (aOR 0.35, 95 % CI 0.24–0.51),
length of stay > 7 days (aOR 0.53, 95 % CI 0.40–0.70),
but a higher odds of chorioamnionitis (aOR 1.83, 95 % CI
1.54–2.17). Hospital charges were lower (-$1,122 (95 % CI
-$1,464 to–$781)), and likewise, the duration of admission
was reduced (-0.47 days (95 % CI -0.52 to–0.42)) for
Table 1 Exclusion from the cohort based for relative or
absolute contraindications to external cephalic version
Exclusion criteria Number of women excluded = 718, 998*
Spontaneous preterm labor 388, 863
Prior cesarean delivery 287, 728
Multiple gestations 141, 758
Oligohydramnios 120, 962
Placenta previa 23,207
Uterine anomaly 17, 248
Age <16 years 7457
Potential placenta accreta 1542
Human immunodeficiency virus 551
*These reasons are not mutually exclusive and any woman could be excluded
for more than one relative contraindication
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women with successful ECV versus women with persistent
breech presentation at the delivery admission, adjusted for
other patient and hospital characteristics.
In the secondary analysis of attempted ECV performed
during the delivery admission versus without ECV at-
tempt, ECV was attempted in 26,455 (2.5 %) women
with breech presentation at delivery admission, with an
ECV success rate (ICD-9-CM code, 652.1x) of 64.8 %.
The associations between attempted ECV during the de-
livery admission and maternal morbidities are presented
in Table 4. The CD rate was significantly lower among
women who attempted ECV during the delivery admis-
sion, versus without ECV attempt (39.2 % vs. 95.1 % re-
spectively, aOR 0.03 (95 % CI 0.03–0.04)). Among
Table 2 Maternal demographic, clinical and hospital characteristics and their association with successful external cephalic version
among breech presentations (N = 1, 079, 576)
Successful ECV
(N = 56, 409) N (%)
Persistent breech presentation at Delivery




16–19 3355 (5.9 %) 79, 603 (7.8 %) 0.73 (0.64–0.83)
20–34 41, 551 (73.7 %) 765, 573 (74.4 %) Reference
35–39 9102 (16.1 %) 143, 789 (14.1 % 1.21 (1.13–1.3)
> = 40 2395 (4.2 %) 37, 517 (3.7 %) 1.25 (1.12–1.39)
Race/Ethnicity:
White 25, 795 (45.7 %) 490, 605 (47.9 %) Reference
Black 2936 (5.2 %) 62, 567 (6.1 %) 0.93 (0.83–1.04)
Hispanic 6797 (12.0 %) 145, 623 (14.2 %) 0.90 (0.81–1.00)
Asian 1711 (3.0 %) 40, 104 (3.9 %) 0.8 (0.69–0.91)
Pacific Islander 1987 (3.5 %) 39, 884 (3.9 %) 0.95 (0.83–1.09)
Other/ Unknown 17, 182 (30.5 %) 244, 384 (23.9 %) 1.24 (0.96–1.60)
Primary expected payer:
Medicare 200 (0.4 %) 5242 (0.5 %) 0.68 (0.48–0.95)
Medicaid 17, 520 (31.1 %) 322, 282 (31.6 %) Reference
Private insurance 35, 157 (62.5 %) 636, 748 (62.4 %) 0.92 (0.87–0.99)
Self-Pay 1734 (3.1 %) 29, 823 (2.9 %) 1.00 (0.87–1.14)
No charge 85 (0.2 %) 2078 (0.2 %) 0.76 (0.44–1.30)
Other 1557 (2.8 %) 24, 670 (2.4 %) 1.09 (0.95–1.24)
Hypertensive disease 3197 (5.7 %) 75, 464 (7.4 %) 0.78 (0.72–0.86)
Diabetes 3375 (6.0 %) 64, 546 (6.3 %) 0.97 (0.9–1.05)
Intrauterine growth restriction 777 (1.4 %) 21, 853 (2.1 %) 0.69 (0.58–0.82)
Grand-multiparity 862 (1.5 %) 8401 (0.8 %) 1.81 (1.50–2.18)
Annual hospital delivery volume:
<=1000 11, 286 (20.0 %) 201, 914 (19.7 %) Reference
1001–2000 14, 118 (25.0 %) 236, 610 (23.1 %) 1.09 (0.93–1.28)
2001–4000 18, 063 (32.0 % 357, 615 (35.0 %) 0.97 (0.84–1.12)
>4000 12, 942 (22.9 %) 227, 028 (22.2 %) 1.18 (0.84–1.65)
Annual hospital cesarean delivery frequency (%):
<20 9698 (17.2 %) 103, 493 (10.1 %) Reference
20–24 13, 686 (24.3 %) 194, 484 (19.0 %) 0.75 (0.62–0.90)
25–29 16, 345 (29.0 %) 292, 255 (28.6 %) 0.60 (0.49–0.73)
30–34 9736 (17.3 %) 217, 125 (21.2 %) 0.48 (0.37–0.64)
> = 35 6943 (12.3 %) 215, 810 (21.1 %) 0.35 (0.29–0.43)
ECV = External Cephalic Version; IUGR = Intrauterine growth retardation
Adjusted for all characteristics in the table; All percentages weighted. Note age is missing for 690 patients and primary payer for 2481 patients. The odds presented are
the odds of having successful external cephalic version versus persistent breech delivery
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women who attempted ECV during the delivery admis-
sion versus without ECV attempt, the odds of a hospital
length of stay > 7 days were significantly lower (aOR =
0.57; 95 % CI 0.39–0.83).
Discussion
Using a nationwide sample of delivery admissions at
term gestation, we observed that only 1 in 20 women with
breech presentation had undergone a successful ECV. Suc-
cessful ECV was associated with a reduction in certain
measures of maternal morbidity and healthcare utilization
compared with persistent breech presentation at delivery.
The strong inverse relationship between successful ECV
and the annual hospital CD frequency suggests that ECV
performance may vary according to institutional delivery
practices [21]. Our finding extends a recent observation by
Rosenstein et al. that the frequency of attempted vaginal
birth after cesarean delivery is inversely correlated with the
primary CD frequency among nulliparous women with
low-risk vertex singleton term pregnancies [22]. This
suggests there may be provider-level, patient-level, and
hospital-level practices that impact use of measures to
avoid cesarean delivery, and that ECV is one such practice.
Management of persistent breech by means of ECV
represents a paradigm shift from breech CD or vaginal
breech delivery [23]. However, based on the high fre-
quency of breech CD in the United States population,
[1] ECV has not been widely performed. In two single
center studies in the United States and United Kingdom,
ECV was performed on less than half the women with
breech presentation, [15, 24] and in 11 African countries,
only 20 % of practitioners offered ECV [25]. Despite the
previously established connection between successful
ECV, vaginal delivery and improved maternal outcomes,
we report that ECV was infrequently performed.
Hesitancy to offer or use ECV is often related to par-
ental or provider concerns for maternal discomfort or
potential complications, including the 1-2 % incidence of
placental abruption and preterm rupture of the mem-
branes (PROM) [26–28]. The low frequency of ECV use
Table 3 Maternal outcomes following successful external cephalic version compared with breech presentation delivery
Successful ECV
(N = 56, 409) N (%)
Persistent Breech Presentation at Delivery
N = (1, 023, 167) N (%)
Adjusted Odds Ratio
(95 % CI)
Cesarean delivery 11, 381 (20.2 %) 970961 (94.9 %) 0.013 (0.011–0.014)
Thromboembolic phenomena 36 (0.1 %) 1024 (0.1 %) 0.64 (0.30–1.38)
Anesthesia complications ** 379 (0.04 %) 0.47 (0.12–1.73)
Chorioamnionitis 924 (1.6 %) 8884 (0.9 %) 1.83 (1.54 to 2.17)
Endometritis 132 (0.2 %) 6518 (0.6 %) 0.36 (0.24–0.52)
Sepsis 132 (0.3 %) 6638 (0.7 %) 0.35 (0.24–0.51)
Blood Transfusion 301 (0.5 %) 7325 (0.7 %) 0.85 (0.65–1.11)
Hysterectomy 42 (0.1 %) 821 (0.1 %) 0.89 (0.44–1.80)
Length of stay > 7 days 328 (0.6 %) 12, 604 (1.2 %) 0.53 (0.40–0.70)
ECV = External cephalic version; **Cell sizes less than 11 cannot be disclosed in accordance with data use agreement; Adjusted Odds Ratio (95 % CI); Adjusted for
all characteristics in Table 1; All percentages weighted. The codes for endometritis are included in the definition for maternal sepsis. The odds presented are the
odds of having the maternal outcome associated with successful external cephalic version compared with breech presentation delivery
Table 4 Maternal outcomes following attempted external cephalic version at delivery admission among women with persistent
breech presentation
ECV attempted
(N = 26,455) N (%)
No ECV attempted
(N = 1,013,855) N (%)
Adjusted Odds Ratio
(95 % CI)
Cesarean delivery 10, 357 (39.2 %) 963, 706 (95.1 %) 0.03 (0.03–0.04)
Thromboembolic phenomena 26 (0.1 %) 1024 (0.1 %) 0.97 (0.40–2.36)
Anesthesia complications ** 374 (0.0 %) 0.49 (0.07–3.49)
Chorioamnionitis 268 (1.0 %) 8807 (0.9 %) 1.14 (0.87 to 1.49)
Endometritis 130 (0.5 %) 6442 (0.6 %) 0.77 (0.52–1.13)
Sepsis 130 (0.5 %) 6561 (0.6 %) 0.76 (0.51–1.11)
Blood transfusion 121 (0.5 %) 7281 (0.7 %) 0.75 (0.47–1.19)
Hysterectomy 19 (0.1 %) 812 (0.1 %) 0.81 (0.30–2.19)
Length of stay > 7 days 167 (0.6 %) 12, 536 (1.2 %) 0.57 (0.39–0.83)
ECV = External cephalic version; **Cell sizes less than 11 cannot be disclosed in accordance with data use agreement; The codes for endometritis are included in
the definition for maternal sepsis. Adjusted Odds Ratio (95 % CI); Adjusted for all characteristics in Table 1; All percentages weighted
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may stem from limited provider experience, or from dis-
comfort in counseling on breech management options, [29]
or performing the technique. Clinicians will need to over-
come barriers for more widespread use of ECV to occur.
Women who underwent successful ECV had a re-
duced likelihood of several measures of maternal mor-
bidity compared to women with persistent breech
presentations. This finding likely relates to the high CD
frequency observed among women who had persistent
breech presentation; Liu et al., reported significant ma-
ternal morbidities such as cardiac arrest, hemorrhage,
hematoma, hysterectomy, infection, thromboembolic phe-
nomena and anesthesia complications associated with
planned cesarean versus vaginal delivery [14]. Moreover,
women with successful ECV in our study had lower mea-
sures of healthcare utilization including hospital costs and
length of stay; this finding is consistent with cost analyses
for successful ECV that indicates a reduction in hospital
costs through increased vaginal delivery practice [30].
Our study is subject to several limitations. First, the
NIS database lacks a specific code for unsuccessful ECV
prior to admission for delivery. As a consequence, our
persistent breech presentation cohort contains a com-
bination of women with no ECV attempt as well as those
with a failed ECV attempt. Furthermore, because we re-
stricted our analysis to delivery admissions coded as suc-
cessful ECV (652.1x) or breech presentation at delivery
(652.2x), it is also possible that some women had suc-
cessful ECV performed prior to the delivery admission,
and then underwent vaginal delivery (without 652.2 or
652.1). However, our overall frequency of observed
breech presentations was consistent with other sources,
suggesting that this kind of miscoding is uncommon or
balanced, and that the diagnostic codes likely captured
most of the breech presentation [31].
Second, maternal and infant admissions cannot be
linked with the NIS database, such that we are unable to
report perinatal and neonatal morbidities associated with
ECV and breech presentation [8, 32]. Future studies
should more closely examine the frequency and relation-
ship between maternal and fetal/neonatal risks associ-
ated with ECV attempts. An analysis of the 2006
national U.S. data reported that neonatal outcomes for
deliveries following successful ECV were similar to non-
ECV breech presentation; however, a failed attempted
ECV was associated with increases in abnormal fetal
heart rate tracings, need for assisted ventilation, and
neonatal intensive care admission [32]. Third, the NIS
lacks clinically nuanced data relevant to an ECV attempt
such as placental location or breech type, as well poten-
tially important elements (e.g., parity, prior vaginal birth
after cesarean delivery, body mass index, or gestational
age at delivery) that could affect or contraindicate ECV;
we excluded 42 % of delivery admissions due to potential
and relative contraindications to ECV [6, 13, 19]. In con-
trast to other smaller databases that reported exclusion
criteria of less than 32 % of the population, [16, 33] our
conservative approach excluded women who some clini-
cians might consider as appropriate candidates for ECV,
such as women with oligohydramnios and a history of
prior CD [34, 35].
Conclusion
In conclusion, a low proportion of women with breech
presentation undergo successful ECV in the United
States. Breech presentation has a disproportionately high
impact on the increasing rate of CD, relative to its fre-
quency in the term pregnant population. The frequen-
cies of successful ECV and annual hospital CDs are
inversely correlated. Furthermore, ECV is associated
with a significant reduction in the frequency of CD and
a number of measures of maternal morbidity. These
findings indicate that increasing the frequency of ECV
may be an important approach to mitigate the high rate
of CD observed in the United States.
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